Home/Filings/4/0001645842-22-000013
4//SEC Filing

Kimball Aaron 4

Accession 0001645842-22-000013

CIK 0001645842other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:15 PM ET

Size

5.2 KB

Accession

0001645842-22-000013

Insider Transaction Report

Form 4
Period: 2022-02-01
Kimball Aaron
Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2022-02-01$5.06/sh25,000$126,605770,283 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
  • [F2]Transaction executed in multiple trades at prices ranging from $4.93 to $5.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Issuer

Zymergen Inc.

CIK 0001645842

Entity typeother

Related Parties

1
  • filerCIK 0001845645

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:15 PM ET
Size
5.2 KB